Toshiya Ishida

Real-world outcomes and risk stratification in patients with metastatic castration-sensitive prostate cancer treated with upfront abiraterone acetate and docetaxel

T. Habuchi, S. Egawa, C. Ohyama, 2022, International Journal of Clinical Oncology.

Real-world survival outcomes of adding docetaxel or abiraterone in patients with high-volume metastatic castration-sensitive prostate cancer: historically controlled, propensity score matched comparison with androgen deprivation therapy

T. Habuchi, S. Egawa, C. Ohyama, 2022, World Journal of Urology.

Short-term outcomes of risk-adapted upfront docetaxel administration in patients with metastatic hormone-sensitive prostate cancer: a multicenter prospective study in Japan

T. Habuchi, C. Ohyama, N. Honma, 2021, Medical Oncology.

Crohn’s Disease Successfully Treated With Infliximab in a Patient Receiving Hemodialysis: Case Report and Review of the Literature

M. Chiba, Satoko Tsuda, Tsuyotoshi Tsuji, 2014, Medicine.

Effect of Levofloxacin on the Efficacy and Adverse Events in Intravesical Bacillus Calmette-Guerin Treatment for Bladder Cancer: Results of a Randomized, Prospective, Multicenter Study.

T. Habuchi, N. Tsuchiya, M. Saito*, 2022, European urology focus.

Real clinical outcomes of nivolumab plus ipilimumab for renal cell carcinoma in patients over 75 years old

T. Habuchi, C. Ohyama, M. Saito*, 2023, International Journal of Clinical Oncology.